A refill is not a single event. A clinical review may come first, followed by a prescription, a payment and a pharmacy shipment. Putting those stages on a calendar can help you notice an unanswered question before it becomes an urgent scramble.
This is an organizational tool, not a medication schedule. The prescriber and pharmacist must provide instructions for use, including what to do if treatment is delayed. Do not calculate a catch-up dose or change your regimen from an expected delivery date.
Record what the service actually requires
Ask whether another assessment or updated information is needed before a refill. Note who requests it and how it should be submitted. An automatic billing setting does not establish that a clinician has approved the next prescription or that the pharmacy has dispatched it.
Keep the care team's contact beside the expected review date. If the requested step is unclear, ask early. Our medication-record guide helps assemble the information a professional may need without relying on an old order confirmation.
Give billing its own calendar entry
A charge date can differ from a shipment date or the start of a supply period. Hers, for example, distinguishes its membership from separate medication plans. LifeMD also describes medication outside the standard care fee. The profiles for Hers and LifeMD show why one recurring payment does not describe every part of the transaction.
Record the selected term, next charge and cancellation procedure. If a longer plan is prepaid, keep the actual purchase confirmation rather than dividing it into monthly amounts and forgetting the original commitment.
Confirm the order stage when something is delayed
Ask whether the outstanding step is clinical review, prescription transmission, pharmacy processing or delivery. The organization responsible for that stage is best placed to explain it. A generic status such as “processing” may need a more specific answer.
If the delay may affect treatment, contact the clinician or pharmacist for instructions. A courier estimate cannot determine what is medically appropriate. Avoid using another person's supply or directions to bridge the uncertainty.
Review the package when it arrives
Compare the current label and instructions with the plan you were given. FDA warns about dosing and product problems involving unapproved GLP-1 medicines; changed packaging or unclear directions deserve professional clarification before use.
Keep the current pharmacy details and discard outdated assumptions, not the records needed to explain a discrepancy. Read the care-change guide if a different service or pharmacy becomes involved. A good calendar helps route the next question; it cannot replace the qualified answer.
Source notes
Checked October 5, 2026. Provider pages document advertised terms. Study summaries identify the scope of our review.
- It can be a lifesaving tool, especially during an emergencyPrimary health resource; checked October 5, 2026
- FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight LossPrimary health resource; checked October 5, 2026
- FAQs | HersProvider public offer; checked October 5, 2026
- Frequently Asked Questions | LifeMD®Provider public offer; checked October 5, 2026